News
Sonya Abdel-Razeq, MD named as Medical Director of Maternal Special Care Unit
Dr. Sonya Abdel-Razeq has been appointed Medical Director of the Yale-New Haven Hospital Maternal Special Care Unit.
Dr. Antonette T. Dulay receives SMFM Research Excellence Award
Dr. Antonette T. Dulay was awarded the Research Excellence Award - Society for Maternal Fetal Medicine at the annual meeting, Dallas, February 6-11, 2012.
Dr. Ericka Werner receives "March of Dimes Best Research in Prematurity" award
Dr. Erika Werner was awarded “The March of Dimes Best Research in Prematurity” at the Society for Maternal Fetal Medicine Meeting, Dallas, February 6-11, 2012.
New Co-Directors named for Yale Maternal-Fetal Medicine Practice
Drs. Urania Magriples & Antonette Dulay have been named Co-Directors of the Yale Maternal-Fetal Medicine Practice.
Related Links
- High-Risk Maternity Services
Yale researchers investigate effects of Heparin in pregnant women
Investigators at Yale Maternal-Fetal Medicine Section discovered that Heparin (a potent anti-coagulation drug) elevates Circulating Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) immunoreactivity in pregnant women.
Yale investigators report findings regarding in-vitro Heparin
A group of investigators at Yale Maternal-Fetal Medicine Section recently reported that in-vitro Heparin induces potentially detrimental proinflammatory and antiangiogenic profile in the trophoblast.
